Loading organizations...
§ Private Profile · Ecublens, Switzerland
Develops automated systems for real-time microbiological water monitoring using flow cytometry for water professionals.
Based in Lausanne, Switzerland, bNovate Technologies develops automated systems for real-time microbiological water monitoring using advanced flow cytometry technology. The organization manufactures specialized hardware solutions, including its flagship BactoSense device, which delivers continuous bacterial detection in water supplies within twenty minutes to replace slower traditional laboratory testing methods. These industrial monitoring systems are actively utilized by drinking water utilities, pharmaceutical manufacturers, food and beverage producers, and environmental researchers to maintain strict microbial quality control standards across their operations. Operating with a current workforce of 45 employees under the strategic direction of Chief Executive Officer Serge Gander, the enterprise recently secured CHF 12 million in Series C venture capital funding led by Emerald Technology Ventures to expand its market reach. bNovate Technologies was originally founded in 2011 by Peter Ryser and Simon Kuenzi.
bNovate Technologies has raised $18.5M across 2 funding rounds.
bNovate Technologies has raised $18.5M in total across 2 funding rounds.
bNovate Technologies SA is a Swiss technology company founded in 2011 that develops automated, real-time microbiological water monitoring solutions using flow cytometry technology.[1][2][3] Its flagship product, BactoSense, is an IoT-connected device that detects bacteria in drinking water in 20 minutes, serving municipal water utilities, industrial clients in food/beverage/pharma, and environmental sectors to prevent contamination and ensure compliance.[1][2][4] With over 40 employees, 300+ units installed across 100+ customers mainly in Europe, and recent expansions into the US, UK, and Germany, bNovate demonstrates strong growth momentum, including awards like the 2023 World Economic Forum Global Freshwater Challenge.[1][3]
The company addresses critical delays in traditional lab testing (1-5 days) by providing near-real-time data for treatment and distribution systems, aligning with UN SDG #6 for safe water access.[1][6]
bNovate Technologies SA was co-founded in 2011 in Lausanne, Switzerland, by Prof. Dr. Peter Ryser (Chairman), Dr. Simon Künzi (Vice-Chairman), and Dr. Fabrice Merenda (now Head of R&D), emerging from a project at École Polytechnique Fédérale de Lausanne (EPFL).[2][3] The idea stemmed from advancing automated analysis instruments for rapid bacterial detection in water, leveraging the founders' expertise in microbiology, engineering, and photonics.[3]
Early traction built through milestones: BactoSense launched commercially in 2017 for drinking water, followed by AQU@Sense MB in 2018 for pharma, BactoSense Multi in 2022 for food/beverage, and international growth including a 2020 Zürich office and 2024 US entry under new CEO Serge Gander.[3] Pivotal wins like the 2019 SME Water Europe Innovation Award and 2023 WEF challenge solidified its path from EPFL spinout to global player with 300+ installations.[1][3]
bNovate rides the wave of digital water management and IoT for sustainability, addressing global water safety amid climate pressures, urbanization, and stricter regulations on microbial risks.[4][6] Timing is ideal with rising demand for real-time monitoring in aging infrastructure and UN SDG #6 priorities, where traditional methods fail.[1][6]
Market forces like water scarcity (affecting 2B+ people) and industry needs in pharma/food favor its tech, influencing the ecosystem by enabling predictive analytics, reducing waste, and partnering with bodies like WEF and Sustainable Switzerland.[3][6] As a Swiss biotech leader, it pushes flow cytometry from labs to field-deployed IoT, democratizing safe water data.
bNovate is poised for accelerated global expansion, building on 2024 US entry and AI-enhanced products to target North America and Asia amid booming smart water markets.[3] Trends like AI-driven predictive maintenance and regulatory pushes for real-time monitoring will shape its trajectory, potentially scaling to 1,000+ units.
Its influence may evolve from European niche leader to key enabler of digital water safety worldwide, reinforcing the mission of safe water, anytime, anywhere through sustained innovation.[6]
bNovate Technologies has raised $18.5M across 2 funding rounds. Most recently, it raised $13.0M Series C in June 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2023 | $13M Series C | Emerald Technology Ventures | — | Announced |
| May 7, 2021 | $5.5M Series B | Celeste Management | Ronald Strassler | Announced |
bNovate Technologies has raised $18.5M in total across 2 funding rounds.
bNovate Technologies's investors include Emerald Technology Ventures, Celeste Management, Ronald Strassler.